Navigation Links
Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
Date:8/30/2010

CINCINNATI, Aug. 31 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today appointed Mark J. Roseman, D.Sc., as the Company's new Senior Vice President and Chief Marketing Officer (CMO), effective immediately. Dr. Roseman brings to Kendle more than 20 years of senior operations leadership and strategic account development experience in the clinical services industry and will have executive-level responsibility for the Company's worldwide sales and strategic partnership development efforts. He will report directly to Chairman and CEO Candace Kendle, PharmD, and will serve on the Company's Executive Committee. Dr. Roseman assumes the Senior Vice President and CMO role from Simon Higginbotham who will transition to an external consulting role providing strategic marketing and business development support services for the Company.

"Mark brings to Kendle a wealth of operational experience and proven sales success in the CRO industry," said Dr. Kendle. "We look forward to his leadership as we drive continued growth in sales and strengthen Kendle's position as a multinational top-tier CRO and strategic partner of choice for our customers."

Dr. Roseman joins Kendle from i3 Research where he was Vice President, Business Operations. His experience includes nearly 13 years with PPD, Inc., where he served most recently as Vice President, Account Management, with responsibility for key customer accounts. Previously, Dr. Roseman was Vice President, Clinical Operations, for PPD responsible for all clinical operations activities in the Wilmington, N.C., and Research Triangle Park offices with oversight of more than 1,100 employees. In this role he provided leadership for the centralized study start-up group as well as the oncology, cardiovascular, anti-viral/anti-infectives, respiratory, ophthalmology, critical care and ge
'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
2. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
3. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
4. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
5. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
6. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
7. Kendle Launches New Global Biostatistics Infrastructure
8. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
9. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
10. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
11. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 Valeant Pharmaceuticals International, ... has priced its previously announced public offering of common ... will issue 23,529,412 common shares at a price of ... $2.0 billion. The Company will file a final prospectus ... S-3 and will make a similar filing with the ...
(Date:6/18/2013)... June 18, 2013  It has become apparent ... Seating and Mobility, a subsidiary company of The ... repair. This appears to be due to the ... field service employees.  (Logo: ... of these clients are complex mobility users with ...
(Date:6/18/2013)... GARDEN CITY, N.Y. , June 18, 2013 ... announced that it has entered into an exclusive ... and Mid-Atlantic regions with eWellness Corporation ("EWC") for ... "An easy to use physical therapy program ... of diabetes and cardiovascular disease," said Chris ...
Breaking Medicine Technology:Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 3
... Aug. 26 Semafore Pharmaceuticals Inc.,announced data presented ... Cancer in Washington, D.C., showing additional antiangiogenic,activity of ... VEGF and Bv8 signaling., PI3K is part ... pathway that,has been shown to play a major ...
... 26 XTENT, Inc.,(Nasdaq: XTNT ) today announced ... trial was published in the most recent issue of ... was,Dr. Pieter R. Stella, M.D., of University Medical Center ... Investigators from 13 clinical,sites across Europe., The one-year ...
Cached Medicine Technology:SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4
(Date:6/19/2013)... Chicago is cracking down on bed bugs. New legislation ... require landlords to exterminate any and all reported bed bug ... also makes tenants responsible for reporting signs of bed bugs ... include disposing of furniture, bedding, and more. , In January ... more bed bug business in Chicago than any other city. ...
(Date:6/19/2013)... North American Seminars combines a live ... with an online continuing education course directed at ... , The two day live physical ... online continuing education course will provide the ... needed to evaluate and treat dizziness and imbalance. ...
(Date:6/19/2013)... A blow to the head; a swift jarring to ... to hours. It’s understandable, but what else may follow ... traumatic brain injury. According to mayoclinic.com , usual ... But many other symptoms may follow, sometimes not for ... include ongoing headaches, dizziness, feeling like you’re in a fog, ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The website ... describing insulin resistance, its harmful effects and tips to ... article and video from HealthNewsWires.com, the author defines ... ability to efficiently remove and process glucose from the ... source required by all cells, organs and systems of ...
(Date:6/19/2013)... 2013 Audibel Hearing Center is ... tinnitus patients, the A2 with Multiflex Tinnitus Technology. ... ringing in the ears. Although bothersome, tinnitus usually ... body. , Using their patent-pending Multiflex Tinnitus Technology, ... comforting sound stimulus that resonates through the patient’s ...
Breaking Medicine News(10 mins):Health News:Chicago Ordinance Requires Landlords and Tenants to Take Responsibility for Bed Bugs 2Health News:New Evidence Based Information on Treatment for Over 8 Million People in the U.S. Affected With Disorders of the Vestibular System 2Health News:Concussions Can Lead to Much More Than a Headache, According to MMTR Health Inc. Founder, Terry Moore, Neuromuscular and Cardiovascular Physiologist 2Health News:Effects of Insulin Resistance and How to Increase Insulin Sensitivity Published in New Video by Health News Wire 2Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2
... best cigarette is no cigarette, but for the millions ... researchers from Cornell University may have found a way ... antioxidant extracts in cigarette filters, the researchers were able ... reduced the amount of cancer-causing free radicals passing through ...
... studies suggests that there may be a positive relationship ... according to a report in the January issue of ... of the JAMA/Archives journals. Amika Singh, Ph.D., of ... Health and Care Research, Amsterdam, the Netherlands, and colleagues ...
... News) -- Losing weight is one of the most common ... in itself, a medical expert says. To shed unwanted ... to face some setbacks and keep on trying, said Dr. ... Gottlieb Memorial Hospital, part of the Loyola University Health System. ...
... News) -- Researchers have identified three gene abnormalities that ... cancer, with one in particular -- the PTEN gene ... Dr. Charis Eng, founding director of the Genomic Medicine ... a news release that her team,s "investigation into the ...
... -- Drug users who inject themselves with methamphetamine are ... abusing other drugs, new research reveals. The magnified ... mixture of social, structural and neurobiological factors, say researchers ... New York City and the University of British Columbia ...
... HealthDay Reporter , FRIDAY, Dec. 30 (HealthDay News) -- ... was 19 years old and a student at the University ... Md., Keys had been suffering the classic symptoms before her ... to just go to the doctor," she recalled. "That,s when ...
Cached Medicine News:Health News:Physical activity, school performance may be linked 2Health News:Persistence Is Key to Losing Weight and Keeping It Off 2Health News:Persistence Is Key to Losing Weight and Keeping It Off 3Health News:Gene Mutations Linked to Thyroid Cancer Risk: Study 2Health News:Meth Users Much More Likely to Try Suicide 2Health News:A Life-Saving Lesson That Took Decades to Learn 2
The Diagnostic Automation, Inc. (DAI) Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the in vitro determination of IgM antibody to Measles in human serum....
... over 30 years, Digisonics has set ... with the first review station, the ... and the best multi-modality reporting., ,DigiView ... image review workstations, professional reporting choices, ...
... Cortisol is a glucocorticoid produced by ... hormone (ACTH). It is secreted with a ... waking in the morning. Cortisol is often ... of hypertension, stress, AIDS, and in the ...
... IMMULITE 2500 is a high-throughput immunoassay ... ,of the IMMULITE 2000 with the important ... technology ,allows assays to be designed for ... times. ,This allows for critical assays such ...
Medicine Products: